Keyphrases
Anaplasmosis
100%
Babesiosis
66%
Systemic Corticosteroids
66%
Anaplasma Phagocytophilum
66%
COVID-19
66%
Systematic Meta-analysis
66%
Pennsylvania
66%
Clinical Diagnosis
66%
Survival Benefit
66%
Clinical Outcomes
66%
Clinical Features
66%
Optimal Duration
66%
Meta-analysis
66%
Medical Center
66%
Corticosteroids
44%
Confidence Interval
44%
Principal Investigator
33%
School of Medicine
33%
State Colleges
33%
Medical Education
33%
Risk Ratio
33%
Corticosteroid Treatment
33%
Tick-borne Diseases
33%
Penn State
33%
Immune Response
33%
Symptom Duration
22%
Disease Severity
22%
Days of Treatment
22%
Health Departments
16%
Western Pennsylvania
16%
Emerging Infections
16%
United States
16%
Babesia Infection
13%
Treatment Duration
11%
Treatment Risk
11%
Protective Association
11%
Randomized Controlled Trial
11%
Mortality Benefit
11%
Corticosteroid Therapy
11%
Random-effects Meta-analysis
11%
Subgroup Analysis
11%
Pooled Analysis
11%
Medicine and Dentistry
Anaplasmosis
100%
Babesiosis
66%
Corticosteroid
66%
Human Granulocytic Anaplasmosis
66%
Meta-Analysis
66%
COVID-19
66%
Systematic Review
66%
Clinical Feature
66%
Infection
50%
Corticosteroid Therapy
44%
Immune Response
33%
Medicine
33%
Tick-Borne Disease
33%
Diseases
22%
Babesia
22%
Awareness
16%
Hope
16%
Clinician
16%
Subgroup Analysis
11%
Observational Study
11%
Treatment Duration
11%
Pooled Analysis
11%
Randomized Controlled Trial
11%